(HealthDay News) — Having a supratherapeutic international normalized ratio (INR) while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older ...

Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head-to-head trials.

About 1 in 6 patients with GG1 prostate cancer have a higher risk of prostate cancer-specific death, data suggest.

Inverse associations seen between higher adherence to three diets with annual rate of total chronic disease accumulation.

(HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends screening adults for unhealthy alcohol use and providing brief behavioral counseling interventions for those engaged in ...

(HealthDay News) — Patients undergoing major surgery who experience alcohol withdrawal syndrome (AWS) and delirium tremens (DT) face significantly higher risks for complications, according to a study ...

Confirmatory trials for cancer drugs that move from accelerated approval to regular approval often fail to demonstrate evidence of OS or QOL benefits.

Using artificial intelligence tools in urology requires an open mind but with appropriate cautions according to clinicians ...

A randomized controlled trial tested a model using donor-derived cell-free DNA for predicting graft rejection.

Medical knowledge is not enough to guard surgeons from premature death, data suggest. Surgeons need further support to protect their own health.

Researchers tested more than 65,000 patients with more than 30 solid tumor types and found the rate of HER2 positivity was about 3%.

AAV relapse following transplantation significantly increased the risk of graft failure and may be linked to ANCA positivity.